Answers are grounded in this paper and cite their sources.
Viral suppression amongst ALHIV at 74% is considerably lower than the WHO target of 95%. Of particular concern for intervention is the lower rates of viral suppression amongst male ALHIV. Greater emphasis should be placed to early enrolment of ALHIV on ART and keeping them engaged in care (beyond 6 months). Furthermore, improved and regular viral load monitoring will help to adequately identify and manage ALHIV with unsuppressed viral load and subsequently switching to second line treatment.
No takes yet. Share an insight, caveat, or question.
Okonji et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: